1. Home
  2. ODP vs ANAB Comparison

ODP vs ANAB Comparison

Compare ODP & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODP
  • ANAB
  • Stock Information
  • Founded
  • ODP 1986
  • ANAB 2005
  • Country
  • ODP United States
  • ANAB United States
  • Employees
  • ODP N/A
  • ANAB N/A
  • Industry
  • ODP Other Specialty Stores
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODP Consumer Discretionary
  • ANAB Health Care
  • Exchange
  • ODP Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • ODP 611.3M
  • ANAB 659.6M
  • IPO Year
  • ODP N/A
  • ANAB 2017
  • Fundamental
  • Price
  • ODP $27.75
  • ANAB $31.83
  • Analyst Decision
  • ODP Hold
  • ANAB Buy
  • Analyst Count
  • ODP 1
  • ANAB 10
  • Target Price
  • ODP $19.00
  • ANAB $50.63
  • AVG Volume (30 Days)
  • ODP 1.4M
  • ANAB 749.6K
  • Earning Date
  • ODP 11-05-2025
  • ANAB 11-04-2025
  • Dividend Yield
  • ODP N/A
  • ANAB N/A
  • EPS Growth
  • ODP N/A
  • ANAB N/A
  • EPS
  • ODP 0.84
  • ANAB N/A
  • Revenue
  • ODP $6,690,000,000.00
  • ANAB $123,164,000.00
  • Revenue This Year
  • ODP N/A
  • ANAB $11.40
  • Revenue Next Year
  • ODP N/A
  • ANAB $8.17
  • P/E Ratio
  • ODP $33.09
  • ANAB N/A
  • Revenue Growth
  • ODP N/A
  • ANAB 304.17
  • 52 Week Low
  • ODP $11.85
  • ANAB $12.21
  • 52 Week High
  • ODP $32.21
  • ANAB $36.54
  • Technical
  • Relative Strength Index (RSI)
  • ODP 71.11
  • ANAB 71.43
  • Support Level
  • ODP $27.65
  • ANAB $29.49
  • Resistance Level
  • ODP $27.97
  • ANAB $32.24
  • Average True Range (ATR)
  • ODP 0.22
  • ANAB 2.08
  • MACD
  • ODP -0.01
  • ANAB 0.81
  • Stochastic Oscillator
  • ODP 96.02
  • ANAB 82.04

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on international operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue stems from the Veyer division.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: